Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan

OBJECTIVE: The objective of this study was to use a discrete choice experiment (DCE) to estimate patients’ preferences for the treatment features, safety, and efficacy of two specific glucagon-like peptide-1 receptor agonists, dulaglutide and liraglutide, among patients with type 2 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelhorn, Heather L, Bacci, Elizabeth D, Poon, Jiat Ling, Boye, Kristina S, Suzuki, Shuichi, Babineaux, Steven M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966566/
https://www.ncbi.nlm.nih.gov/pubmed/27524889
http://dx.doi.org/10.2147/PPA.S109289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966566/
https://www.ncbi.nlm.nih.gov/pubmed/27524889
http://dx.doi.org/10.2147/PPA.S109289

Ejemplares similares